XOMA XOMA Corp
Price (delayed)
$24.23
Market cap
$290.24M
P/E Ratio
N/A
Dividend/share
N/A
EPS
-$1.65
Enterprise value
$306.46M
XOMA has built a significant portfolio of products that are licensed to and being developed by other biotechnology and pharmaceutical companies. The Company's portfolio of partner-funded programs spans multiple stages
Highlights
The EPS has soared by 59% YoY and by 52% from the previous quarter
XOMA's net income has surged by 58% YoY and by 41% QoQ
The company's quick ratio fell by 44% YoY and by 35% QoQ
The company's equity fell by 8% YoY and by 3.4% QoQ
Key stats
What are the main financial stats of XOMA
Market
Valuations
Earnings
Shares outstanding
11.98M
Market cap
$290.24M
Enterprise value
$306.46M
Price to earnings (P/E)
N/A
Price to book (P/B)
3.49
Price to sales (P/S)
9.95
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
10.76
Revenue
$28.49M
Gross profit
$28.49M
Operating income
-$39.98M
Net income
-$19.29M
EBIT
-$11.11M
EBITDA
-$10.84M
Free cash flow
-$37.52M
Per share
Balance sheet
Liquidity
EPS
-$1.65
EPS diluted
-$1.65
Free cash flow per share
-$3.21
Book value per share
$6.95
Revenue per share
$2.43
TBVPS
$16.7
Total assets
$221.28M
Total liabilities
$139.36M
Debt
$119.2M
Equity
$81.92M
Working capital
$101.23M
Debt to equity
1.46
Current ratio
5.15
Quick ratio
4.45
Net debt/EBITDA
-1.5
Margins
Efficiency
Dividend
EBITDA margin
-38%
Gross margin
100%
Net margin
-67.7%
Operating margin
-140.3%
Return on assets
-8.5%
Return on equity
-22.1%
Return on invested capital
-5.9%
Return on capital employed
-5.6%
Return on sales
-39%
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A
XOMA stock price
How has the XOMA stock price performed over time
Intraday
3.81%
1 week
14.4%
1 month
15.77%
1 year
-5.5%
YTD
-7.8%
QTD
21.58%
Financial performance
How have XOMA's revenue and profit performed over time
Revenue
$28.49M
Gross profit
$28.49M
Operating income
-$39.98M
Net income
-$19.29M
Gross margin
100%
Net margin
-67.7%
The net margin has surged by 93% year-on-year and by 55% since the previous quarter
XOMA's operating margin has soared by 84% YoY and by 42% from the previous quarter
XOMA's net income has surged by 58% YoY and by 41% QoQ
The revenue has grown by 32% from the previous quarter
Growth
What is XOMA's growth rate over time
Valuation
What is XOMA stock price valuation
P/E
N/A
P/B
3.49
P/S
9.95
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
10.76
The EPS has soared by 59% YoY and by 52% from the previous quarter
XOMA's price to book (P/B) is 13% more than its 5-year quarterly average of 3.1 and 2.6% more than its last 4 quarters average of 3.4
The company's equity fell by 8% YoY and by 3.4% QoQ
The stock's P/S is 64% below its 5-year quarterly average of 27.7 and 56% below its last 4 quarters average of 22.8
The revenue has grown by 32% from the previous quarter
Efficiency
How efficient is XOMA business performance
The ROS has soared by 96% YoY and by 61% from the previous quarter
The company's return on invested capital has surged by 87% YoY and by 49% QoQ
The return on assets has surged by 72% year-on-year and by 43% since the previous quarter
XOMA's ROE has soared by 50% YoY and by 42% from the previous quarter
Dividends
What is XOMA's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A
There are no recent dividends present for XOMA.
Financial health
How did XOMA financials performed over time
XOMA's total assets is 59% greater than its total liabilities
The company's quick ratio fell by 44% YoY and by 35% QoQ
XOMA's current ratio is down by 41% year-on-year and by 32% since the previous quarter
The debt is 46% greater than the equity
The company's equity fell by 8% YoY and by 3.4% QoQ
The debt has declined by 4.2% year-on-year
All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise
specified. Data from 
and Sharadar.